Data is not available at this time.
HCA Healthcare, Inc. is a leading provider of comprehensive healthcare services in the United States, operating a diversified network of hospitals, outpatient facilities, and specialized care centers. The company generates revenue primarily through patient care services, including inpatient and outpatient treatments, diagnostic procedures, and emergency care. Its extensive footprint includes 182 hospitals and numerous freestanding facilities, positioning it as one of the largest for-profit healthcare providers in the U.S. HCA Healthcare serves a broad patient base, leveraging economies of scale to maintain cost efficiencies while delivering high-quality care. The company operates in a highly regulated and competitive industry, where its scale, operational expertise, and integrated service offerings provide a competitive edge. Its market position is reinforced by strategic locations in high-growth regions and partnerships with physicians and payers, ensuring steady patient inflows and revenue stability. HCA Healthcare’s focus on operational excellence and technology adoption further strengthens its ability to adapt to evolving healthcare demands.
HCA Healthcare reported revenue of $70.6 billion for the latest fiscal year, reflecting its dominant position in the healthcare sector. Net income stood at $5.76 billion, with a diluted EPS of $22, underscoring robust profitability. The company generated $10.51 billion in operating cash flow, demonstrating strong cash conversion capabilities. Capital expenditures of $4.88 billion highlight ongoing investments in facility upgrades and expansion, ensuring long-term growth.
HCA Healthcare’s earnings power is evident in its consistent profitability and efficient capital deployment. The company’s ability to generate substantial operating cash flow supports its growth initiatives and debt management. With a focus on high-margin services and operational leverage, HCA maintains a disciplined approach to capital allocation, balancing reinvestment with shareholder returns.
HCA Healthcare’s balance sheet reflects a solid financial position, with $1.93 billion in cash and equivalents. However, total debt of $45.24 billion indicates significant leverage, common in capital-intensive healthcare operations. The company’s strong cash flow generation provides ample coverage for debt servicing and strategic investments, ensuring financial stability despite the high debt load.
HCA Healthcare has demonstrated steady growth, driven by organic expansion and strategic acquisitions. The company’s dividend policy, with a dividend per share of $2.7, reflects a commitment to returning capital to shareholders while maintaining flexibility for reinvestment. Growth trends are supported by demographic tailwinds and increasing demand for healthcare services, positioning HCA for sustained revenue growth.
With a market capitalization of $90.46 billion, HCA Healthcare trades at a premium, reflecting its leadership in the healthcare sector. The company’s beta of 1.47 indicates higher volatility relative to the market, typical for healthcare stocks. Market expectations are anchored on HCA’s ability to maintain growth and profitability amid regulatory and competitive pressures.
HCA Healthcare’s strategic advantages include its scale, operational expertise, and diversified service offerings. The company is well-positioned to capitalize on long-term healthcare demand, supported by its investments in technology and facility upgrades. While regulatory and cost pressures persist, HCA’s focus on efficiency and quality care provides a resilient foundation for future growth.
Company filings, market data
show cash flow forecast
| Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |